Enzo Biochem Inc. (NYSE: ENZ) has received a license to a comprehensive non-PCR based amplification technology that allows ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE